NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178125 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Franziska Grän und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: NFATC Transcription Factors, B-Lymphocytes, Dermatitis, Allergic Contact, Dermatitis, Contact. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Interdisziplinäres Zentrum für Klinische Forschung Würzburg, UAE University grants.
Abstract (Originalsprache)
Allergic contact dermatitis (ACD) is a frequent inflammatory skin disease that evolves upon exposure to contact allergens in sensitized individuals. Both the adaptive and innate immune system play pivotal roles in the pathogenesis of ACD. While the importance of T cells is undisputed, the relevance of B lymphocytes is less clear. The published data support a critical role for NFATc1 in B cell activation. Therefore, we investigated the impact of NFATc1 on B cell function during murine contact hypersensitivity (CHS), the mouse model for human ACD. Compared with wild-type mice, B cell-specific ablation of NFATc1 (Nfatc1f/f x mb1-cre) resulted in significantly diminished CHS responses measured by ear thickness (0.81 ± 0.02 mm vs. 0.48 ± 0.02 mm (p = 0.0007)) to the obligate contact allergen 2,4,6-trinitrochlorobenzene, accompanied by a marked increase in the frequency of IL-10-producing regulatory B cells. Flow cytometric analysis showed that IL-4- and IL-17-producing CD4+ T cells were reduced, while IFN-γ-producing CD4+ T cells were marginally increased in Nfatc1f/f x mb1-cre mice. In conclusion, NFATc1 mediates CHS responses by modulating the development of IL-10-producing B cells. These findings support the compelling notion that targeting NFATc1 may represent a potential therapeutic strategy for allergic responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, 97080 Würzburg, Germany.
- Department of Molecular Pathology, Institute of Pathology, University of Würzburg, 97078 Würzburg, Germany.
- Department of Biology, College of Science, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
ORCID-Profile: Muhammad Azeem, Matthias Goebeler, Andreas Kerstan, Khalid Muhammad
Förderung
- Interdisziplinäres Zentrum für Klinische Forschung Würzburg
- UAE University grants
Zitieren
APA
Grän, F., Azeem, M., Serfling, E., Goebeler, M., Kerstan, A., & Muhammad, K. (2025). NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178125
Vancouver
Grän F, Azeem M, Serfling E, Goebeler M, Kerstan A, Muhammad K. NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178125
BibTeX
@article{Grn2025,
author = {Grän, Franziska and Azeem, Muhammad and Serfling, Edgar and Goebeler, Matthias and Kerstan, Andreas and Muhammad, Khalid},
title = {NFATc1 Abrogation in B Cells Ameliorates Contact Hypersensitivity Responses},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178125}
}
EUVIMED